[
  {
    "ts": null,
    "headline": "IQVIA to acquire Charles River drug discovery assets",
    "summary": "The expanded offerings will allow IQVIA to serve a broader range of drug modalities and therapeutic areas.",
    "url": "https://finnhub.io/api/news?id=bd93a34295c1aff7a7bb271b0b28ae1f8f0033a3baa0f51431f30a990d218c0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772106179,
      "headline": "IQVIA to acquire Charles River drug discovery assets",
      "id": 139231063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "The expanded offerings will allow IQVIA to serve a broader range of drug modalities and therapeutic areas.",
      "url": "https://finnhub.io/api/news?id=bd93a34295c1aff7a7bb271b0b28ae1f8f0033a3baa0f51431f30a990d218c0b"
    }
  },
  {
    "ts": null,
    "headline": "IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap",
    "summary": "IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods. The transaction is intended to expand IQVIA's end to end drug discovery capabilities and broaden its therapeutic coverage. For investors watching NYSE:IQV, this move connects directly to IQVIA's role as a data driven partner for biopharma and healthcare clients. The...",
    "url": "https://finnhub.io/api/news?id=f40dfd5132b5f2e09b99c042e8e849e4629b4b608e048a11adcfb5def93b459d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772086165,
      "headline": "IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap",
      "id": 139229607,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods. The transaction is intended to expand IQVIA's end to end drug discovery capabilities and broaden its therapeutic coverage. For investors watching NYSE:IQV, this move connects directly to IQVIA's role as a data driven partner for biopharma and healthcare clients. The...",
      "url": "https://finnhub.io/api/news?id=f40dfd5132b5f2e09b99c042e8e849e4629b4b608e048a11adcfb5def93b459d"
    }
  }
]